NEW YORK (GenomeWeb News) — Venture capital investment in the genomics, bioinformatics, and proteomics segments increased five-fold during the fourth quarter of 2006 over the same period in 2005, according to a GenomeWeb Daily News roundup of companies that disclosed receiving investments.
Venture capitalists invested around $140 million in genome tool and technology companies in the final quarter of 2006, nearly 5 times the $31.6 million they invested in the same period of 2005.
Private-equity investors flocked to genomics businesses, while venture funding among bioinformatics companies dipped slightly.
Investors spent $70 million on companies with core businesses in genomics during the fourth quarter of 2006, almost 5 times more than the $15.2 million they spent year over year.
Venture funding for businesses focused on bioinformatics over the period declined 4.4 percent to $13 million from $13.6 million in the same quarter in 2005.